- Illuminated Chop Using an Illuminated Chopper in Cataract Surgery: on the Way to Minimal-energy Phacoemulsification
-
Kim J, Lee KW, Lee DY, Eom YS, Nam DH
- KMID: 2526505
- J Korean Ophthalmol Soc.
- 2022 Feb;63(2):160-165.
- doi: 10.3341/jkos.2022.63.2.160
Purpose: To minimize ultrasound power use and surgical phaco time in illuminated chop cataract surgery. Methods: The charts of patients who underwent senile cataract surgery by a single surgeon were reviewed... -
- CITED
-
- Close
- SHARE
-
- Close
- Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
-
Li X, Huang H, Xu B, Guo H, Lin Y, Ye S, Yi J, Li W, Wu X, Wang W, Zhan H, Xie D, Peng J, Cao Y, Pu X, Guo C, Hong H, Wang Z, Fang X, Zhou Y, Lin S, Liu Q, Lin T
- KMID: 2454284
- Cancer Res Treat.
- 2019 Jul;51(3):919-932.
- doi: 10.4143/crt.2018.230
PURPOSE: Rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone administered every 3 weeks (R-CHOP-21) is the standard care for diffuse large B-cell lymphoma (DLBCL). It is unknown whether the dose-dense R-CHOP... -
- CITED
-
- Close
- SHARE
-
- Close
- Endoplasmic Reticulum Stress Induces MUC5AC and MUC5B Expression in Human Nasal Airway Epithelial Cells
-
Kim MH, Bae CH, Choi YS, Na HG, Song SY, Kim YD
- KMID: 2447427
- Clin Exp Otorhinolaryngol.
- 2019 May;12(2):181-189.
- doi: 10.21053/ceo.2018.00493
OBJECTIVES: Endoplasmic reticulum (ER) stress is known to be associated with inflammatory airway diseases, and three major transmembrane receptors: double-stranded RNA-activated protein kinase-like ER kinase, inositol requiring enzyme 1, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of L-asparaginase-based regimens compared to anthracycline-based regimens in newly diagnosed extranodal NK/T-cell lymphoma, nasal type: a single Mexican center experience
-
Ãvila Milord AA, Aguilar Hernández MM, Demichelis Gómez R, Agreda Vásquez GP
- KMID: 2429320
- Blood Res.
- 2018 Sep;53(3):210-217.
- doi: 10.5045/br.2018.53.3.210
BACKGROUND: Extranodal NK/T-cell lymphoma, nasal type (ENKTCL) has a high prevalence in Asia and Latin American countries, such as Mexico, where it encompasses 40% of all T-cell non-Hodgkin lymphomas. Historically,... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent
-
Sekiguchi , Hamano A, Kitagawa T, Kurihara Y, Ito K, Kurimoto M, Watanabe K, Hirano K, Noto S, Yamada K, Takezako N
- KMID: 2451029
- Blood Res.
- 2018 Jun;53(2):117-122.
- doi: 10.5045/br.2018.53.2.117
BACKGROUND: Waldenström Macroglobulinemia (WM) is a rare subtype of indolent B-cell lymphoma, and prospective randomized studies on WM are scarce. The R-CHOP therapy [rituximab (R), cyclophosphamide, hydroxy-doxorubicin, vincristine, and prednisone]... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphoma
-
Choi EJ, Hong JY, Yoon DH, Kang J, Park CS, Huh J, Chae EJ, Lee Y, Ryu JS, Suh C
- KMID: 2405063
- Blood Res.
- 2017 Dec;52(4):270-275.
- doi: 10.5045/br.2017.52.4.270
BACKGROUND: While cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) is the most commonly used chemotherapeutic regimen for patients with peripheral T-cell lymphomas (PTCLs), elderly patients are more vulnerable to associated toxicities.... -
- CITED
-
- Close
- SHARE
-
- Close
- MDL-12330A potentiates TRAIL-induced apoptosis in gastric cancer cells through CHOP-mediated DR5 upregulation
-
Lim SC, Han SI
- KMID: 2384453
- Korean J Physiol Pharmacol.
- 2017 Jul;21(4):397-405.
- doi: 10.4196/kjpp.2017.21.4.397
MDL-12330A is a widely used adenylyl cyclase (AC) inhibitor that blocks AC/cAMP signaling. In this study, we demonstrated a novel antitumor activity of this drug in gastric carcinoma (GC) cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Human Herpesvirus 8–Unrelated Primary Effusion Lymphoma–Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone
-
Shin J, Lee JO, Choe JY, Bang SM, Lee JS
- KMID: 2367525
- Cancer Res Treat.
- 2017 Jan;49(1):274-278.
- doi: 10.4143/crt.2016.076
Primary effusion lymphoma (PEL) is a rare type of non-Hodgkin’s lymphoma arising from a B-cell lineage characterized by the formation of malignant effusion in body cavities without evidence of a... -
- CITED
-
- Close
- SHARE
-
- Close
- Utility Analysis for Pegfilgrastim in DLBCL Patients on R-CHOP Regimen
-
Jung HW, Kim JM, Min MS, Lee YM, Bang JS
- KMID: 2226406
- Korean J Clin Pharm.
- 2015 Sep;25(3):151-158.
- doi: 10.0000/kjcp.2015.25.3.151
OBJECTIVE: This study was designed to compare pegfilgrastim and filgrastim in diffuse large B-cell lymphoma (DLBCL) patients treated with a rituximab with cyclophosphamide, hydroxydaunorubicin, oncovin, and prednisone (R-CHOP) regimen in... -
- CITED
-
- Close
- SHARE
-
- Close
- Prophylactic Effect of Pegfilgrastim on Febrile Neutropenia in Patients with Non-Hodgikin's Lymphoma
-
Jo J, Bang JS
- KMID: 2068831
- Korean J Clin Pharm.
- 2015 Jun;25(2):80-93.
- doi: 10.0000/kjcp.2015.25.2.80
OBJECTIVE: Pegfilgrastim is recently introduced that is long acting G-CSF for prophylaxis of febrile neutropenia. Treatment of non-Hodgikin's lymphoma (NHL) with R-CHOP is classified with relative high risk of febrile... -
- CITED
-
- Close
- SHARE
-
- Close
- Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth
-
Lee EJ, Ahn KH, Hong SC, Lee EH, Park Y, Kim BS
- KMID: 2314021
- Obstet Gynecol Sci.
- 2014 Nov;57(6):526-529.
- doi: 10.5468/ogs.2014.57.6.526
Lymphoma, especially non-Hodgkin's lymphoma is extremely rare in pregnancy. A 24-year-old pregnant woman was diagnosed with diffuse large B-cell lymphoma (DLBCL), a subgroup of non-Hodgkin's lymphoma, at 24 weeks' gestation,... -
- CITED
-
- Close
- SHARE
-
- Close
- Patterns of Neutropenia and Risk Factors for Febrile Neutropenia of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
-
Choi YW, Jeong SH, Ahn MS, Lee HW, Kang SY, Choi JH, Jin UR, Park JS
- KMID: 2069930
- J Korean Med Sci.
- 2014 Nov;29(11):1493-1500.
- doi: 10.3346/jkms.2014.29.11.1493
Febrile neutropenia (FN) is the major toxicity of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) regimen in the treatment of diffuse large B-cell lymphoma (DLBCL). The prediction of neutropenia... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Surgical Parameters and Outcomes According to the Phacoemulsification Technique
-
Kim S, Ko DA, Kim JY, Kim MJ, Tchah HW
- KMID: 2338441
- J Korean Ophthalmol Soc.
- 2013 Sep;54(9):1353-1358.
PURPOSE: To compare intraoperative parameters and postoperative results between divide-and-conquer and multiple phaco-chop technique. METHODS: Two different techniques were performed by one operator on the patients with bilateral cataract. One eye... -
- CITED
-
- Close
- SHARE
-
- Close
- Myxoid Liposarcoma with Cartilaginous Differentiation: A Case Study with Cytogenetical Analysis
-
Kim H, Hwangbo W, Ahn S, Kim S, Kim I, Kim CH
- KMID: 2277447
- Korean J Pathol.
- 2013 Jun;47(3):284-288.
Myxoid liposarcoma is a subtype of liposarcoma. This specific subtype can be identified based on its characteristic histological and cytogenetical features. The tumor has a fusion transcript of the CHOP... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party Registry
-
Yi HG, Kim JS, Suh C, Kim WS, Kwak JY, Lee JS, Kim YS, Joo YD, Min YH, Lee HG, Yoon SS, Won JH, Park S, Kim HC, Kim CS
- KMID: 2172909
- Blood Res.
- 2013 Jun;48(2):115-120.
- doi: 10.5045/br.2013.48.2.115
BACKGROUND: This study aimed to survey the clinical spectrum of diffuse large B-cell lymphoma (DLBCL) in terms of epidemiology, pathologic subtypes, stage, and prognostic index as well as treatment outcomes. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of CHOP in Squamous Tumor of the Uterine Cervix
-
Chu HH, Bae JS, Kim KM, Park HS, Cho DH, Jang KY, Moon WS, Kang MJ, Lee DG, Chung MJ
- KMID: 2277487
- Korean J Pathol.
- 2012 Oct;46(5):463-469.
BACKGROUND: High-risk human papillomavirus (HR-HPV) infection and abnormal p53 expression are closely involved in carcinogenesis of squamous cell carcinoma (SqCC) of uterine cervix. Recent studies have suggested that virus-induced endoplasmic... -
- CITED
-
- Close
- SHARE
-
- Close
- A phase I/II study of bortezomib plus CHOP every 2 weeks (CHOP-14) in patients with advanced-stage diffuse large B-cell lymphomas
-
Kim JE, Yoon DH, Jang G, Lee DH, Kim S, Park CS, Huh J, Kim WS, Park J, Lee JH, Lee SI, Suh C
- KMID: 2251971
- Korean J Hematol.
- 2012 Mar;47(1):53-59.
- doi: 10.5045/kjh.2012.47.1.53
BACKGROUND: Bortezomib targets molecular dysregulation of nuclear factor-kappaB activation and cell cycle control, which are characteristic features of diffuse large B-cell lymphoma (DLBCL). We evaluated the safety and efficacy of... -
- CITED
-
- Close
- SHARE
-
- Close
- Primary cutaneous B-cell lymphoblastic lymphoma in an elderly man
-
Cho SY, Lee SS, Back DH, Lim KA, Lee YR, Kang HJ
- KMID: 2251991
- Korean J Hematol.
- 2011 Dec;46(4):283-286.
- doi: 10.5045/kjh.2011.46.4.283
Precursor B-cell lymphoblastic lymphoma (B-LBL) is an uncommon high-grade neoplasm of immature B cells. It occurs predominantly in childhood with extranodal involvement such as skin and bone. Therefore, primary cutaneous... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Value of Immunohistochemical Biomarkers at Different Cut-off Values in Patients with Diffuse Large B-cell Lymphoma Treated with CHOP Chemotherapy
-
Oh S, Koo DH, Suh C, Kim S, Park BH, Kang J, Huh J
- KMID: 1786010
- J Korean Med Sci.
- 2011 Dec;26(12):1556-1562.
- doi: 10.3346/jkms.2011.26.12.1556
Many predictive models have been proposed for better stratification of diffuse large B-cell lymphoma (DLBCL). Hans' algorithm has been widely used as standard to sub-classify DLBCL into germinal center B-cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Addition of rituximab to the CHOP regimen has no benefit in patients with primary extranodal diffuse large B-cell lymphoma
-
Jang G, Yoon DH, Kim S, Lee DH, Lee SW, Huh J, Suh C
- KMID: 1782774
- Korean J Hematol.
- 2011 Jun;46(2):103-110.
- doi: 10.5045/kjh.2011.46.2.103
BACKGROUND: The addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy (R-CHOP) has significantly improved clinical outcomes for patients with diffuse large B-cell lymphoma (DLBCL). However, new predictors... -
- CITED
-
- Close
- SHARE
-
- Close
